2025年3月10日，复旦大学附属华山医院刘杰教授、骆菲菲研究员团队在Cancer Cell（《肿瘤细胞》，中科院一区，影响因子48.8分）发表题为 Targeting tumor monocyte-intrinsic PD-L1 by ...

ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ ...

Drs Ursula A. Matulonis and Katherine Fuh discuss the molecular classification and genetics of endometrial cancer as well as when to rebiopsy, research updates, and what's to come in the future.

A new PET radiotracer can effectively visualize Nectin-4, an emerging biomarker found in triple-negative breast cancer (TNBC) ...

Ashley Robinson, 35, told doctors about his family history of colon cancer, but says they insisted he was "too young” for the ...

这项研究揭示了中性粒细胞与肿瘤细胞之间的直接相互作用及其在乳腺癌侵袭性中的关键作用。这些发现不仅增进了我们对肿瘤微环境中免疫细胞与肿瘤细胞相互作用的理解，还为开发新的乳腺癌治疗策略提供了潜在的靶点。例如，通过靶向中性粒细胞与肿瘤细胞之间的相互作用，可能能够抑制肿瘤的侵袭和转移，改善患者的预后。

Metastatic melanoma, also known as stage IV melanoma, is a type of skin cancer that spreads to other parts of the body. It is ...

PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...

7, 2025 — A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new ... Breakthrough in Childhood Brain Cancer ...

Hong Kong-listed Innovent Biologics Inc. is considering a licensing partnership to develop a cancer drug that’s showing ...

Single-cell analysis revealed the molecular triggers that drive stem cells to become cancerous, which may help inform ...